Evidence map›Paper›PMID 17603538›Full record

ReviewEMBO reports2007

The exosome and RNA quality control in the nucleus.

Stepanka Vanacova, Richard Stefl

Abstract readReview
In one paragraph

Review in EMBO reports, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed.

  1. Article
  2. Article
  3. Nuclear mRNA export.Acta biochimica et biophysica Sinica · 2024
    Review
  4. Article
  5. Polyadenylated versions of small non-coding RNAs inMicrobial cell (Graz, Austria) · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. The long noncoding RNARNA (New York, N.Y.) · 2019
    Article
  13. Article
  14. Article
  15. Erroneous ribosomal RNAs promote the generation of antisense ribosomal siRNA.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Stepanka VanacovaBiozentrum, University of Basel, Klingelbergstrasse 50/70, CH-4057 Basel, Switzerland.
Richard Stefl

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To control the quality of RNA biogenesis in the nucleus, cells use sophisticated molecular machines. These machines recognize and degrade not only RNA trimmings--the leftovers of RNA processing--but also incorrectly processed RNAs that contain defects. By using this mechanism, cells ensure that only high-quality RNAs are engaged in protein synthesis and other cellular processes. The exosome--a complex of several exoribonucleolytic and RNA-binding proteins--is the central 3'-end RNA degradation and processing factor in this surveillance apparatus. The exosome operates with auxiliary factors that stimulate its activity and recruit its RNA substrates in the crowded cellular environment. In this review, we discuss recent structural and functional data related to the nuclear quality-control apparatus, including the long-awaited structure of the human exosome and its activity.

Indexed as

Cell NucleusExoribonucleasesHumansModels, BiologicalModels, MolecularPolyadenylationRNARNA-Binding ProteinsExoribonucleasesRNARNA-Binding Proteins

Identifiers

PMID17603538
PMCPMC1905902

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.